Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75% The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript EBS earnings call for the period ending December 31, 2023.…
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…